Vol 3 (September 2018): AME Medical Journal

Editorial 
Stressing the metabolic powers of fibroblast growth factor 21
Aaron L. Magno, Lakshini Y. Herat, Revathy Carnagarin, Markus P. Schlaich, Vance B. Matthews
AME Medical Journal  
2018;
3:
97  
(30 September 2018) 
PDF Full Text (2229) COI Form Open Access Get Permission
Editorial 
Attempt to predict early recurrence of prostate cancer following prostatectomy through machine learning
Yan Gu, Xiaozeng Lin, Anil Kapoor, Wenjuan Mei, Damu Tang
AME Medical Journal  
2018;
3:
96  
(28 September 2018) 
PDF Full Text (1989) COI Form Open Access Get Permission
Editorial 
Bile acid dependent and independent roles of fibroblast growth factor 15/19 in liver regeneration
Sandra M. W. van de Wiel, Stan F. J. van de Graaf
AME Medical Journal  
2018;
3:
95  
(28 September 2018) 
PDF Full Text (1867) COI Form Open Access Get Permission
Editorial 
Acute kidney injury in patients with decompensated cirrhosis: knowing the cause is often difficult
Mohammed Faisal Rahman, Harold M. Szerlip
AME Medical Journal  
2018;
3:
94  
(27 September 2018) 
PDF Full Text (1906) COI Form Open Access Get Permission
Editorial 
Diabetes mellitus and liver disease
Luigi Terrana, Andrea Mancuso
AME Medical Journal  
2018;
3:
93  
(25 September 2018) 
PDF Full Text (2345) COI Form Open Access Get Permission
Editorial 
Prognostic factors during androgen deprivation therapy in patients with hormone naive metastatic prostate cancer: is changes in hemoglobin level significant?
Daisaku Hirano, Toshiyuki Yoshida
AME Medical Journal  
2018;
3:
92  
(25 September 2018) 
PDF Full Text (3308) COI Form Open Access Get Permission
Editorial 
Periprostatic adipose tissue interacts with prostate cancer to promote aggressive disease
Ryan Stuchbery, Niall M. Corcoran
AME Medical Journal  
2018;
3:
91  
(20 September 2018) 
PDF Full Text (2274) COI Form Open Access Get Permission